Centre for Pharmacoepidemiology/Unit of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Clin Gastroenterol Hepatol. 2012 Nov;10(11):1246-52. doi: 10.1016/j.cgh.2012.08.018. Epub 2012 Aug 21.
BACKGROUND & AIMS: Little is known about complications from ulcerative colitis (UC) or Crohn's disease (CD) during pregnancy and delivery. We assessed complications by using data from a large, population-based cohort.
We analyzed data from 1209 women with UC, 787 women with CD, and 10,773 women without these diseases (the comparison group) by using the Medical Birth, Patient, and Prescribed Drug Registers of all residents in Sweden. All the women included in the analysis gave birth to a single infant between October 2006 and December 2009. We used data on medical treatment, surgery, and hospital admissions to assess disease activity. Risks of pregnancy and delivery complications were determined from adjusted odds ratios (aORs) with 95% confidence intervals (CIs).
The risk of venous thromboembolism was increased among women with UC (aOR, 3.78; 95% CI, 1.52-9.38), particularly for those with flaring disease. Women with CD had a higher risk of antepartum hemorrhage (aOR, 1.66; 95% CI, 1.12-2.45), with the highest risks among those with no disease activity. Risks of elective cesarean delivery were more than doubled among women with UC (aOR, 2.44; 95% CI, 2.06-2.88) or CD (aOR, 2.31; 95% CI, 1.89-2.83). Women with UC (aOR, 1.39; 95% CI, 1.13-1.70) or CD (aOR, 1.50; 95% CI, 1.17-1.92) had increased risk for emergency cesarean delivery. Women with an inactive UC or flaring CD had the highest risks of cesarean delivery.
Women with UC or CD have more complications during pregnancy and delivery than women without these diseases. Disease activity affects mode of delivery, and thrombophilic events present differently in women with UC vs CD.
溃疡性结肠炎(UC)或克罗恩病(CD)孕妇及分娩期的并发症知之甚少。我们利用来自大型人群队列的数据评估了并发症。
我们利用瑞典所有居民的医疗出生、患者和处方药物登记数据,分析了 1209 例 UC 女性、787 例 CD 女性和 10773 例无这些疾病的女性(对照组)的数据。所有纳入分析的女性在 2006 年 10 月至 2009 年 12 月间单胎分娩。我们使用药物治疗、手术和住院数据来评估疾病活动度。采用调整后的比值比(aOR)及其 95%置信区间(CI)评估妊娠和分娩并发症的风险。
UC 女性发生静脉血栓栓塞的风险增加(aOR,3.78;95%CI,1.52-9.38),特别是疾病活动期的女性。CD 女性产前出血风险较高(aOR,1.66;95%CI,1.12-2.45),无疾病活动的女性风险最高。UC(aOR,2.44;95%CI,2.06-2.88)或 CD(aOR,2.31;95%CI,1.89-2.83)女性选择性剖宫产的风险增加一倍以上。UC(aOR,1.39;95%CI,1.13-1.70)或 CD(aOR,1.50;95%CI,1.17-1.92)女性急诊剖宫产的风险增加。无活动期 UC 或疾病活动期 CD 的女性剖宫产风险最高。
与无这些疾病的女性相比,UC 或 CD 女性在妊娠和分娩期间并发症更多。疾病活动度影响分娩方式,UC 与 CD 女性的血栓形成事件表现不同。